These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8972981)

  • 1. Survey of immunity to measles in schoolchildren in Cork.
    Foley-Nolan C; Conlon C; Keane E; O'Sullivan M; Ryan F
    Commun Dis Rep CDR Rev; 1996 Nov; 6(12):R172-5. PubMed ID: 8972981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.
    Enquselassie F; Ayele W; Dejene A; Messele T; Abebe A; Cutts FT; Nokes DJ
    Epidemiol Infect; 2003 Jun; 130(3):507-19. PubMed ID: 12825737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign.
    Ramsay M; Gay N; Miller E; Rush M; White J; Morgan-Capner P; Brown D
    Commun Dis Rep CDR Rev; 1994 Nov; 4(12):R141-6. PubMed ID: 7529089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N; Ramsay M; Cohen B; Hesketh L; Morgan-Capner P; Brown D; Miller E
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R17-21. PubMed ID: 9046124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
    Mbabazi WB; Nanyunja M; Makumbi I; Braka F; Baliraine FN; Kisakye A; Bwogi J; Mugyenyi P; Kabwongera E; Lewis RF
    Health Policy Plan; 2009 Jul; 24(4):261-9. PubMed ID: 19282484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.